Clinical Trial Update: Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing adjusted high-dose chemotherapy with autologous stem cell transplant versus conventional immunochemotherapy in elderly patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: University Hospital Freiburg | Conditions: Primary Central Nervous System Lymphoma | Phase 3 | Status: RECRUITING